基于动态对比增强MRI的瘤内及瘤周影像组学术前预测浸润性乳腺癌导管内成分
本研究利用DCE-MRI提取瘤内及瘤周影像组学特征,构建并验证预测浸润性乳腺癌导管内成分的模型;联合瘤内及瘤周影像组学特征模型诊断效能最优,原发队列AUC 0.821,验证队列AUC 0.815,可能有助于乳腺癌保乳手术前的个体化手术规划。
要点
- 联合瘤内及瘤周影像组学特征模型在原发队列AUC为0.821(0.758-0.874)。
- 联合模型在验证队列AUC为0.815(0.730-0.882),敏感度0.778(0.577-0.914)。
- 瘤周影像组学特征包含预测浸润性乳腺癌导管内成分的有用信息。
核心结论
- 基于DCE-MRI联合瘤内及瘤周特征的影像组学模型对浸润性乳腺癌导管内成分显示出良好的术前预测能力,可能有助于乳腺癌患者保乳手术前的个体化手术规划。
研究设计与样本
- 开发并验证影像组学模型的队列研究,原发队列183例连续患者(45例IBC-IC和138例IBC),验证队列111例患者(27例IBC-IC和84例IBC),从MRI可见肿瘤的瘤内及瘤周区域提取208个影像组学特征,采用最小绝对收缩和选择算子筛选特征并结合临床特征构建预测模型。
诊断标准与关键数值
- 共构建4个预测IBC-IC的影像组学模型:瘤内影像组学标签、瘤周影像组学标签、瘤周影像组学列线图、联合瘤内及瘤周影像组学标签;联合模型诊断效能最优,原发队列AUC 0.821(0.758-0.874)、敏感度0.822(0.680-0.920)、特异度0.739(0.658-0.810),验证队列AUC 0.815(0.730-0.882)、敏感度0.778(0.577-0.914)、特异度0.738(0.631-0.828)。
临床应用与阅片要点
- 术前预测浸润性乳腺癌导管内成分对保乳手术规划至关重要。
- 瘤周影像组学特征包含预测浸润性乳腺癌导管内成分的有用信息。
- 影像组学是一种有前景的无创方法,可能有助于乳腺癌患者保乳手术前的个体化手术规划。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop and validate radiomic models for preoperative prediction of intraductal component in invasive breast cancer (IBC-IC) using the intratumoral and peritumoral features derived from dynamic contrast-enhanced MRI (DCE-MRI).
METHODS: The prediction models were developed in a primary cohort of 183 consecutive patients from September 2017 to December 2018, consisting of 45 IBC-IC and 138 invasive breast cancers (IBC). The validation cohort of 111 patients (27 IBC-IC and 84 IBC) from February 2019 to January 2020 was enrolled to test the prediction models. A total of 208 radiomic features were extracted from the intratumoral and peritumoral regions of MRI-visible tumors. Then the radiomic features were selected and combined with clinical characteristics to construct predicting models using the least absolute shrinkage and selection operator. The area under the curve (AUC) of receiver operating characteristic, sensitivity, and specificity were used to evaluate the performance of radiomic models.
RESULTS: Four radiomic models for prediction of IBC-IC were built including intratumoral radiomic signature, peritumoral radiomic signature, peritumoral radiomic nomogram, and combined intratumoral and peritumoral radiomic signature. The combined intratumoral and peritumoral radiomic signature had the optimal diagnostic performance, with the AUC, sensitivity, and specificity of 0.821 (0.758-0.874), 0.822 (0.680-0.920), and 0.739 (0.658-0.810) in the primary cohort and 0.815 (0.730-0.882), 0.778 (0.577-0.914), and 0.738 (0.631-0.828) in the validation cohort.
CONCLUSIONS: The radiomic model based on the combined intratumoral and peritumoral features from DCE-MRI showed a good ability to preoperatively predict IBC-IC, which might facilitate the individualized surgical planning for patients with breast cancer before breast-conserving surgery.
KEY POINTS: •·Preoperative prediction of intraductal component in invasive breast cancer is crucial for breast-conserving surgery planning. • Peritumoral radiomic features of invasive breast cancer contain useful information to predict intraductal components. •·Radiomics is a promising non-invasive method to facilitate individualized surgical planning for patients with breast cancer before breast-conserving surgery.
引用
- Xu, Liu, Chen, et al. Intratumoral and peritumoral radiomics based on dynamic contrast-enhanced MRI for preoperative prediction of intraductal component in invasive breast cancer. Eur Radiol. 2022. PMID: 35079887. doi:10.1007/s00330-022-08539-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。